TargetEpidermal growth factor receptor [T790M,L858R](Homo sapiens (Human))
Celgene Avilomics Research
US Patent
Celgene Avilomics Research
US Patent
Affinity DataIC50: <1nMpH: 7.5 T: 2°CAssay Description:Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and
EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif.,
1.13x ATP (AS001A) and...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor [T790M,L858R](Homo sapiens (Human))
Celgene Avilomics Research
US Patent
Celgene Avilomics Research
US Patent
Affinity DataIC50: <1nMpH: 7.5 T: 2°CAssay Description:Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and
EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif.,
1.13x ATP (AS001A) and...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor [T790M,L858R](Homo sapiens (Human))
Celgene Avilomics Research
US Patent
Celgene Avilomics Research
US Patent
Affinity DataIC50: <1nMpH: 7.5 T: 2°CAssay Description:Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and
EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif.,
1.13x ATP (AS001A) and...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor [T790M,L858R](Homo sapiens (Human))
Celgene Avilomics Research
US Patent
Celgene Avilomics Research
US Patent
Affinity DataIC50: <1nMpH: 7.5 T: 2°CAssay Description:Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and
EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif.,
1.13x ATP (AS001A) and...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor [T790M,L858R](Homo sapiens (Human))
Celgene Avilomics Research
US Patent
Celgene Avilomics Research
US Patent
Affinity DataIC50: <1nMpH: 7.5 T: 2°CAssay Description:Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and
EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif.,
1.13x ATP (AS001A) and...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor [T790M,L858R](Homo sapiens (Human))
Celgene Avilomics Research
US Patent
Celgene Avilomics Research
US Patent
Affinity DataIC50: <1nMpH: 7.5 T: 2°CAssay Description:Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and
EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif.,
1.13x ATP (AS001A) and...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor [T790M,L858R](Homo sapiens (Human))
Celgene Avilomics Research
US Patent
Celgene Avilomics Research
US Patent
Affinity DataIC50: 5.5nMpH: 7.5 T: 2°CAssay Description:Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and
EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif.,
1.13x ATP (AS001A) and...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor [T790M,L858R](Homo sapiens (Human))
Celgene Avilomics Research
US Patent
Celgene Avilomics Research
US Patent
Affinity DataIC50: 5.5nMpH: 7.5 T: 2°CAssay Description:Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and
EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif.,
1.13x ATP (AS001A) and...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor [T790M,L858R](Homo sapiens (Human))
Celgene Avilomics Research
US Patent
Celgene Avilomics Research
US Patent
Affinity DataIC50: 5.5nMpH: 7.5 T: 2°CAssay Description:Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and
EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif.,
1.13x ATP (AS001A) and...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor [T790M,L858R](Homo sapiens (Human))
Celgene Avilomics Research
US Patent
Celgene Avilomics Research
US Patent
Affinity DataIC50: 5.5nMpH: 7.5 T: 2°CAssay Description:Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and
EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif.,
1.13x ATP (AS001A) and...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor [T790M,L858R](Homo sapiens (Human))
Celgene Avilomics Research
US Patent
Celgene Avilomics Research
US Patent
Affinity DataIC50: 5.5nMpH: 7.5 T: 2°CAssay Description:Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and
EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif.,
1.13x ATP (AS001A) and...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor [T790M,L858R](Homo sapiens (Human))
Celgene Avilomics Research
US Patent
Celgene Avilomics Research
US Patent
Affinity DataIC50: 5.5nMpH: 7.5 T: 2°CAssay Description:Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and
EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif.,
1.13x ATP (AS001A) and...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor [T790M,L858R](Homo sapiens (Human))
Celgene Avilomics Research
US Patent
Celgene Avilomics Research
US Patent
Affinity DataIC50: 5.5nMpH: 7.5 T: 2°CAssay Description:Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and
EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif.,
1.13x ATP (AS001A) and...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor [T790M,L858R](Homo sapiens (Human))
Celgene Avilomics Research
US Patent
Celgene Avilomics Research
US Patent
Affinity DataIC50: 5.5nMpH: 7.5 T: 2°CAssay Description:Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and
EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif.,
1.13x ATP (AS001A) and...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor [T790M,L858R](Homo sapiens (Human))
Celgene Avilomics Research
US Patent
Celgene Avilomics Research
US Patent
Affinity DataIC50: 5.5nMpH: 7.5 T: 2°CAssay Description:Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and
EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif.,
1.13x ATP (AS001A) and...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor [T790M,L858R](Homo sapiens (Human))
Celgene Avilomics Research
US Patent
Celgene Avilomics Research
US Patent
Affinity DataIC50: 5.5nMpH: 7.5 T: 2°CAssay Description:Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and
EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif.,
1.13x ATP (AS001A) and...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor [T790M,L858R](Homo sapiens (Human))
Celgene Avilomics Research
US Patent
Celgene Avilomics Research
US Patent
Affinity DataIC50: 5.5nMpH: 7.5 T: 2°CAssay Description:Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and
EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif.,
1.13x ATP (AS001A) and...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor [T790M,L858R](Homo sapiens (Human))
Celgene Avilomics Research
US Patent
Celgene Avilomics Research
US Patent
Affinity DataIC50: 5.5nMpH: 7.5 T: 2°CAssay Description:Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and
EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif.,
1.13x ATP (AS001A) and...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor [T790M,L858R](Homo sapiens (Human))
Celgene Avilomics Research
US Patent
Celgene Avilomics Research
US Patent
Affinity DataIC50: 20nMpH: 7.5 T: 2°CAssay Description:Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and
EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif.,
1.13x ATP (AS001A) and...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor [T790M,L858R](Homo sapiens (Human))
Celgene Avilomics Research
US Patent
Celgene Avilomics Research
US Patent
Affinity DataIC50: 20nMpH: 7.5 T: 2°CAssay Description:Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and
EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif.,
1.13x ATP (AS001A) and...More data for this Ligand-Target Pair
Affinity DataIC50: 20nMpH: 7.5 T: 2°CAssay Description:Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and
EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif.,
1.13x ATP (AS001A) and...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor [T790M,L858R](Homo sapiens (Human))
Celgene Avilomics Research
US Patent
Celgene Avilomics Research
US Patent
Affinity DataIC50: 20nMpH: 7.5 T: 2°CAssay Description:Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and
EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif.,
1.13x ATP (AS001A) and...More data for this Ligand-Target Pair
Affinity DataIC50: 20nMpH: 7.5 T: 2°CAssay Description:Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and
EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif.,
1.13x ATP (AS001A) and...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor [T790M,L858R](Homo sapiens (Human))
Celgene Avilomics Research
US Patent
Celgene Avilomics Research
US Patent
Affinity DataIC50: 20nMpH: 7.5 T: 2°CAssay Description:Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and
EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif.,
1.13x ATP (AS001A) and...More data for this Ligand-Target Pair
Affinity DataIC50: 20nMpH: 7.5 T: 2°CAssay Description:Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and
EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif.,
1.13x ATP (AS001A) and...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor [T790M,L858R](Homo sapiens (Human))
Celgene Avilomics Research
US Patent
Celgene Avilomics Research
US Patent
Affinity DataIC50: 55nMpH: 7.5 T: 2°CAssay Description:Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and
EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif.,
1.13x ATP (AS001A) and...More data for this Ligand-Target Pair
Affinity DataIC50: 65nMpH: 7.5 T: 2°CAssay Description:Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and
EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif.,
1.13x ATP (AS001A) and...More data for this Ligand-Target Pair
Affinity DataIC50: 65nMpH: 7.5 T: 2°CAssay Description:Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and
EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif.,
1.13x ATP (AS001A) and...More data for this Ligand-Target Pair
Affinity DataIC50: 65nMpH: 7.5 T: 2°CAssay Description:Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and
EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif.,
1.13x ATP (AS001A) and...More data for this Ligand-Target Pair
Affinity DataIC50: 65nMpH: 7.5 T: 2°CAssay Description:Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and
EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif.,
1.13x ATP (AS001A) and...More data for this Ligand-Target Pair
Affinity DataIC50: 65nMpH: 7.5 T: 2°CAssay Description:Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and
EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif.,
1.13x ATP (AS001A) and...More data for this Ligand-Target Pair
Affinity DataIC50: 65nMpH: 7.5 T: 2°CAssay Description:Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and
EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif.,
1.13x ATP (AS001A) and...More data for this Ligand-Target Pair
Affinity DataIC50: 200nMpH: 7.5 T: 2°CAssay Description:Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and
EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif.,
1.13x ATP (AS001A) and...More data for this Ligand-Target Pair
Affinity DataIC50: 200nMpH: 7.5 T: 2°CAssay Description:Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and
EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif.,
1.13x ATP (AS001A) and...More data for this Ligand-Target Pair
Affinity DataIC50: 200nMpH: 7.5 T: 2°CAssay Description:Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and
EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif.,
1.13x ATP (AS001A) and...More data for this Ligand-Target Pair
Affinity DataIC50: 200nMpH: 7.5 T: 2°CAssay Description:Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and
EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif.,
1.13x ATP (AS001A) and...More data for this Ligand-Target Pair
Affinity DataIC50: 200nMpH: 7.5 T: 2°CAssay Description:Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and
EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif.,
1.13x ATP (AS001A) and...More data for this Ligand-Target Pair
Affinity DataIC50: 200nMpH: 7.5 T: 2°CAssay Description:Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and
EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif.,
1.13x ATP (AS001A) and...More data for this Ligand-Target Pair
Affinity DataIC50: 200nMpH: 7.5 T: 2°CAssay Description:Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and
EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif.,
1.13x ATP (AS001A) and...More data for this Ligand-Target Pair
Affinity DataIC50: 200nMpH: 7.5 T: 2°CAssay Description:Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and
EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif.,
1.13x ATP (AS001A) and...More data for this Ligand-Target Pair
Affinity DataIC50: 650nMpH: 7.5 T: 2°CAssay Description:Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and
EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif.,
1.13x ATP (AS001A) and...More data for this Ligand-Target Pair
Affinity DataIC50: 650nMpH: 7.5 T: 2°CAssay Description:Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and
EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif.,
1.13x ATP (AS001A) and...More data for this Ligand-Target Pair
Affinity DataIC50: 650nMpH: 7.5 T: 2°CAssay Description:Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and
EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif.,
1.13x ATP (AS001A) and...More data for this Ligand-Target Pair
Affinity DataIC50: 650nMpH: 7.5 T: 2°CAssay Description:Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and
EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif.,
1.13x ATP (AS001A) and...More data for this Ligand-Target Pair
Affinity DataIC50: 650nMpH: 7.5 T: 2°CAssay Description:Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and
EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif.,
1.13x ATP (AS001A) and...More data for this Ligand-Target Pair
Affinity DataIC50: >1.00E+3nMpH: 7.5 T: 2°CAssay Description:Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and
EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif.,
1.13x ATP (AS001A) and...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor [T790M,L858R](Homo sapiens (Human))
Celgene Avilomics Research
US Patent
Celgene Avilomics Research
US Patent
Affinity DataEC50: 55nMAssay Description:To assess phosphor-EGFR signaling, blots were probed with rabbit anti-Phospho-EGFR (Y1068) and mouse total anti-EGFR antibodies. Phospho-EGFR signal ...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor [T790M,L858R](Homo sapiens (Human))
Celgene Avilomics Research
US Patent
Celgene Avilomics Research
US Patent
Affinity DataEC50: 55nMAssay Description:To assess phosphor-EGFR signaling, blots were probed with rabbit anti-Phospho-EGFR (Y1068) and mouse total anti-EGFR antibodies. Phospho-EGFR signal ...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor [T790M,L858R](Homo sapiens (Human))
Celgene Avilomics Research
US Patent
Celgene Avilomics Research
US Patent
Affinity DataEC50: 55nMAssay Description:To assess phosphor-EGFR signaling, blots were probed with rabbit anti-Phospho-EGFR (Y1068) and mouse total anti-EGFR antibodies. Phospho-EGFR signal ...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor [T790M,L858R](Homo sapiens (Human))
Celgene Avilomics Research
US Patent
Celgene Avilomics Research
US Patent
Affinity DataEC50: 300nMAssay Description:To assess phosphor-EGFR signaling, blots were probed with rabbit anti-Phospho-EGFR (Y1068) and mouse total anti-EGFR antibodies. Phospho-EGFR signal ...More data for this Ligand-Target Pair